메뉴 건너뛰기

추천
검색
질문

논문 기본 정보

자료유형
학술저널
저자정보
(Gyeongsang National University) (Gyeongsang National University)
저널정보
한국생약학회 Natural Product Sciences Natural Product Sciences Vol.30 No.4
발행연도
수록면
291 - 299 (9page)
DOI
10.20307/nps.2024.30.4.291

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
이 논문의 연구방법이 궁금하신가요?
🏆
연구결과
이 논문의 연구결과가 궁금하신가요?
AI에게 요청하기
추천
검색
질문

초록· 키워드

Benign prostatic hyperplasia (BPH) is one the most common urinary disorders in elderly men, occurring when the prostate, which surrounding the urethra, undergoes abnormal enlarges and obstructs urine flow. Within the prostate, testosterone is converted to dihydrotestosterone (DHT) by the lipophilic enzyme 5α-reductase. Excessive accumulation of DHT binds to androgen receptors (AR), causing the hyperproliferation of stromal and epithelial cells, which increases the size of the prostate. In the process of exploring new materials with efficacy for improving BPH from halophytes native to Korea, Suaeda glauca (Bunge) Bunge was found as a promising candidate. S. glauca is an annual plant belonging to the Amaranthaceae family. In human prostate cell lines RWPE-1 and LNCaP, the ethanolic extract of S. glauca (ESG) effectively reduced the expression levels of AR, 5α-reductase type 2 (5αR2), proliferating cell nuclear antigen (PCNA) and prostate-specific antigen (PSA) proteins, compared to finasteride, a positive control. HPLC-DAD analysis of ESG using eight compounds isolated from S. glauca identified kaempferol-3-O-β-D-glucoside as one of the major components in ESG. Among the compounds 1–8, the effects of hydroxytyrosol (8) on BPH-related proteins were most remarkable in both cell lines. These results suggest that S. glauca and its bioactive compounds may be promising novel candidates for the prevention or treatment of BPH
상세정보 수정요청해당 페이지 내 제목·저자·목차·페이지
정보가 잘못된 경우 알려주세요!

목차

  1. Abstract
  2. Introduction
  3. Experimental
  4. Results and Discussion
  5. References

참고문헌

참고문헌 신청

최근 본 자료

전체보기
UCI(KEPA) : I410-151-25-02-092207094